Medpace

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Medpace and other ETFs, options, and stocks.

About MEDP

Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries. The firm's services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. 

CEO
August James Troendle
CEOAugust James Troendle
Employees
6,200
Employees6,200
Headquarters
Cincinnati, Ohio
HeadquartersCincinnati, Ohio
Founded
1992
Founded1992
Employees
6,200
Employees6,200

MEDP Key Statistics

Market cap
13.57B
Market cap13.57B
Price-Earnings ratio
30.80
Price-Earnings ratio30.80
Dividend yield
Dividend yield
Average volume
328.39K
Average volume328.39K
High today
$479.88
High today$479.88
Low today
$460.51
Low today$460.51
Open price
$466.70
Open price$466.70
Volume
120.81K
Volume120.81K
52 Week high
$628.92
52 Week high$628.92
52 Week low
$250.05
52 Week low$250.05

Stock Snapshot

With a market cap of 13.57B, Medpace(MEDP) trades at $478.26. The stock has a price-to-earnings ratio of 30.80.

On 2026-03-09, Medpace(MEDP) stock traded between a low of $460.51 and a high of $479.88. Shares are currently priced at $478.26, which is +3.9% above the low and -0.3% below the high.

The Medpace(MEDP)'s current trading volume is 120.81K, compared to an average daily volume of 328.39K.

During the past year, Medpace(MEDP) stock moved between $250.05 at its lowest and $628.92 at its peak.

During the past year, Medpace(MEDP) stock moved between $250.05 at its lowest and $628.92 at its peak.

MEDP News

Simply Wall St 4d
Is Medpace’s 32% Revenue Surge And Reinvestment Strategy Altering The Investment Case For MEDP?

In its most recent quarter, Medpace Holdings reported US$708.5 million in revenue, a 32% year-on-year increase that surpassed analyst estimates by 3.3% and deli...

Is Medpace’s 32% Revenue Surge And Reinvestment Strategy Altering The Investment Case For MEDP?
Simply Wall St 5d
Medpace Holdings Valuation Check After Strong Quarter And 32% Revenue Growth

Medpace Holdings (MEDP) recently reported a 32% year over year revenue increase to US$708.5 million, surpassing analyst expectations on both revenue and full ye...

Medpace Holdings Valuation Check After Strong Quarter And 32% Revenue Growth
TipRanks 7d
Medpace initiated with an Outperform at RBC Capital

RBC Capital analyst Ryan Halsted initiated coverage of Medpace (MEDP) with an Outperform rating and $522 price target The company is the most efficient CRO – co...

Analyst ratings

56%

of 16 ratings
Buy
25%
Hold
56.3%
Sell
18.8%

People also own

Based on the portfolios of people who own MEDP. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.